Feature selection and classifier performance on diverse bio- logical datasets

BMC Bioinformatics

Volumn 15, Issue 13, 2014, Pages

  Hemphill, Edward ^a   Lindsay, James ^a   Lee, Chih ^a   Măndoiu, Ion I ^a   Nelson, Craig E ^a  

^a Department of Molecular and Cell Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BIOMARKERS; CELL CULTURE; CELLS; CLUSTERING ALGORITHMS; DATA MINING; DISEASES; FEATURE EXTRACTION; GENE EXPRESSION; GENES; PROTEINS; RNA;

CLASSIFICATION ALGORITHM; CLASSIFIER PERFORMANCE; CLINICAL APPLICATION; FEATURE SELECTION AND CLASSIFICATION; GENE EXPRESSION MICROARRAY; HIGH DIMENSIONAL DATA; PREDICTIVE ACCURACY; PROTEIN EXPRESSIONS;

CLASSIFICATION (OF INFORMATION);

MESSENGER RNA; MICRORNA; PROTEIN; TUMOR MARKER;

ALGORITHM; BIOLOGICAL MODEL; BIOLOGY; CLASSIFICATION; COPY NUMBER VARIATION; DATA MINING; DNA MICROARRAY; FACTUAL DATABASE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL CULTURE;

ALGORITHMS; BIOMARKERS, TUMOR; COMPUTATIONAL BIOLOGY; DATA MINING; DATABASES, FACTUAL; DNA COPY NUMBER VARIATIONS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84961615850     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-15-S13-S4     Document Type: Article

References (38)

1. Abeel T, Helleputte T, Van de Peer Y, Dupont P, Saeys Y: Robust biomarker identification for cancer diagnosis with ensemble feature selection methods. Bioinformatics. 2010, 26 (3): 392-398. 10.1093/bioinformatics/btp630.
2. Huang CM, Lin YC, Lin YJ, Chang SL, Lo LW, Hu YF, Chiang CE, Wang KL, Chen SA: Risk stratification and clinical outcomes in patients with acute pulmonary embolism. Clinical Biochemistry. 2011
3. Parry RM, Jones W, Stokes TH, Phan JH, Moffitt RA, Fang H, Shi L, Oberthuer A, Fischer M, Tong W, Wang MD: k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. The Pharmacogenomics Journal. 2010, 10 (4): 292-309. 10.1038/tpj.2010.56.
4. Ein-Dor L, Zuk O, Domany E: Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proceedings of the National Academy of Sciences. 2006, 103 (15): 5923-5928. 10.1073/pnas.0601231103.
5. Maruvada P, Srivastava S: Joint National Cancer Institute-Food and Drug Administration Workshop on Research Strategies, Study Designs, and Statistical Approaches to Biomarker Validation for Cancer Diagnosis and Detection. Cancer Epidemiology Biomarkers & Prevention. 2006, 15 (6): 1078-1082. 10.1158/1055-9965.EPI-05-0432.
6. Haury AC, Gestraud P, Vert JP: The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures. PLoS ONE. 2011, 6 (12): e28210+-10.1371/journal.pone.0028210.
7. Lai C, Reinders M, Veer LV, Wessels L: A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinformatics. 2006, 7 (235):
8. Lee JW, Lee JB, Park M, Song SH: An extensive comparison of recent classification tools applied to microarray data. Computational Statistics & Data Analysis. 2005, 48 (4): 869-885. 10.1016/j.csda.2004.03.017.
9. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y: CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set. Cancer Research. 2012, 72 (14): 3499-3511. 10.1158/0008-5472.CAN-12-1370.
10. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, Weinstein JN: DNA fingerprinting of the NCI-60 cell line panel. Molecular cancer therapeutics. 2009, 8 (4): 713-724. 10.1158/1535-7163.MCT-08-0921.
11. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D, Cossman J, Kaldjian EP, Scudiero DA, Petricoin E, Liotta L, Lee JK, Weinstein JN: Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Molecular Cancer Therapeutics. 2007, 6 (3): 820-832. 10.1158/1535-7163.MCT-06-0650.
12. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA: Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines. Cancer Res. 2007, 67 (6): 2456-2468. 10.1158/0008-5472.CAN-06-2698.
13. Savas S, Briollais L, Ibrahim-zada I, Jarjanazi H, Choi YH, Musquera M, Fleshner N, Venkateswaran V, Ozcelik H: A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca2+ Signaling in Selenium Resistance. PLoS ONE. 2010, 5 (9): e12601+-10.1371/journal.pone.0012601.
14. Weng L, Ziliak D, Im HK, Gamazon ER, Philips S, Nguyen AT, Desta Z, Skaar TC, the Consortium on Breast Cancer Pharmacogenomics COBRA, Flockhart DA, Huang RS: Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation. Annals of Oncology. 2013, 24 (7): 1867-1873. 10.1093/annonc/mdt125.
15. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay d: Scikit-learn: Machine Learning in Python. Journal of Machine Learning Research. 2011, 12: 2825-2830.
16. Guyon I, Weston J, Barnhill S, Vapnik V: Gene Selection for Cancer Classification using Support Vector Machines. Machine Learning. 2002, 46 (1-3): 389-422.
17. Rogers J, Gunn S: Identifying Feature Relevance Using a Random Forest. Subspace, Latent Structure and Feature Selection. 2006, 173-184.
18. Geurts P, Ernst D, Wehenkel L: Extremely Randomized Trees. Machine Learning. 2006, 63 (1): 3-42. 10.1007/s10994-006-6226-1.
19. Knerr S, Personnaz L, Dreyfus G: Single-layer learning revisited: a stepwise procedure for building and training a neural network. Neurocomputing: Algorithms, Architectures and Applications. NATO ASI Series. 1990, Springer-Verlag, 68: 41-50.
20. Ben-Hur A, Ong CS, Sonnenburg S, Scholkopf B, Ratsch G: Support vector machines and kernels for computational biology. PLoS computational biology. 2008, 4 (10): e1000173-10.1371/journal.pcbi.1000173.
21. Liao JGG, Chin KVV: Logistic regression for disease classification using microarray data: model selection in a large p and small n case. Bioinformatics. 2007, 23 (15): 1945-51. 10.1093/bioinformatics/btm287.
22. Breiman L, Friedman J, Stone CJ, Olshen RA: Classification and Regression Trees. Chapman & Hall/CRC. 1984, 1
23. Teramoto R: Balanced gradient boosting from imbalanced data for clinical outcome prediction. Statistical Applications in Genetics and Molecular Biology. 2009, 8 (1): 1-19.
24. Smialowski P, Frishman D, Kramer S: Pitfalls of supervised feature selection. Bioinformatics. 2010, 26 (3): 440-443. 10.1093/bioinformatics/btp621.
25. Cawley GC, Talbot NLC: Preventing Over-Fitting during Model Selection via Bayesian Regularisation of the Hyper-Parameters. J Mach Learn Res. 2007, 8: 841-861.
26. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Colon Adenocarcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
27. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Rectum Adenocarcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
28. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Kidney Renal Clear Cell Carcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
29. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Kidney Renal Papillary Cell Carcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
30. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Lung Adenocarcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
31. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Lung Squamous Cell Carcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
32. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Brain Lower Grade Glioma (Primary solid tumor cohort. Tech rep. 2014, Broad Institute of MIT and Harvard
33. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Glioblastoma Multiforme (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
34. Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for Ovarian Serous Cystadenocarcinoma (Primary solid tumor cohort). Tech rep. 2014, Broad Institute of MIT and Harvard
35. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC: mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities. Molecular Cancer Therapeutics. 2010, 9 (5): 1080-1091. 10.1158/1535-7163.MCT-09-0965.
36. Fawcett T: An introduction to ROC analysis. Pattern Recognition Letters. 2006, 27 (8): 861-874. 10.1016/j.patrec.2005.10.010.
37. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN, Kirsch IR: Karyotypic complexity of the NCI-60 drug-screening panel. Cancer research. 2003, 63 (24): 8634-8647.
38. Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML, Sellers WR: "Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harbor symposia on quantitative biology. 2005, 70: 25-34. 10.1101/sqb.2005.70.016.